|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0300 USD | -3.23% |
|
-5.66% | +15.38% |
| 05-19 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3.23% | -5.66% | -16.67% | +1,900.00% | +15.38% | -61.29% | -96.51% | -99.14% | -99.62% | 7.95M | |
| +1.59% | +2.85% | +18.33% | +9.72% | +1.62% | +39.32% | +0.52% | +28.40% | +86.29% | 78.32B | |
| +2.77% | +4.78% | +14.16% | +5.71% | -8.20% | -0.98% | +28.10% | +10.12% | - | 51.1B | |
| -0.84% | +0.09% | -10.29% | -4.70% | -6.50% | +20.92% | +175.02% | +137.49% | +227.56% | 49.18B | |
| -0.13% | +7.42% | +6.35% | +10.27% | -23.43% | -49.33% | -50.09% | -55.63% | +14.79% | 44.71B | |
| +0.80% | +2.46% | +3.78% | +7.49% | +18.15% | +59.13% | -24.15% | -38.84% | -33.70% | 30.72B | |
| +1.84% | +0.87% | +2.81% | +22.32% | +22.06% | +53.80% | +86.83% | +58.01% | +36.94% | 24.44B | |
| +9.86% | +7.94% | -19.82% | +8.87% | +100.64% | +126.53% | -40.68% | -85.70% | - | 23.62B | |
| +4.29% | +9.40% | +10.03% | +5.39% | +24.39% | +3.95% | +230.49% | +27.66% | - | 21.05B | |
| +1.66% | -3.70% | -4.27% | +4.14% | +36.18% | +66.13% | +121.72% | +173.26% | +317.31% | 16.61B | |
| +2.03% | +5.48% | +7.85% | +25.36% | +10.45% | +81.37% | +161.87% | +56.16% | - | 16.51B | |
| +3.92% | +28.53% | +26.48% | +16.45% | -11.79% | -7.79% | +782.09% | +422.86% | +6,201.99% | 15.07B | |
| +3.82% | +6.31% | +6.79% | +18.04% | +7.37% | +11.30% | -29.58% | -18.33% | -35.56% | 12.35B | |
| +1.24% | -2.41% | -13.37% | -2.13% | +16.48% | +103.00% | +193.27% | +315.83% | +2,662.86% | 10.95B | |
| +1.17% | -4.30% | -13.04% | +6.78% | +32.41% | +135.43% | +181.69% | +444.99% | - | 9.66B | |
| +6.04% | +26.35% | +29.41% | +103.47% | +264.66% | +351.13% | +395.80% | +4.42% | - | 7.25B | |
| +0.69% | +2.12% | +13.06% | +13.81% | -4.91% | -21.46% | -21.46% | -50.92% | -47.46% | 7.05B | |
| +9.98% | +15.07% | -6.29% | -5.12% | +14.28% | +37.31% | +263.27% | +245.22% | - | 6.24B | |
| +2.18% | +1.40% | +10.88% | +15.88% | +2.38% | +13.35% | +69.64% | -3.68% | - | 6.15B | |
| -0.59% | +2.31% | +17.45% | +29.80% | +84.39% | +136.58% | +327.06% | +479.28% | - | 5.93B | |
| Average | +2.45% | +5.35% | +4.18% | +109.58% | +29.80% | +54.92% | +137.75% | +102.57% | +848.31% | 21.85B | |
| Weighted average by Cap. | +2.12% | +5.08% | +5.88% | +10.27% | +13.73% | +37.71% | +91.16% | +63.00% | +503.03% |
- Stock Market
- Stocks
- ADAPY Stock
- Sector Adaptimmune Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
